{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:51:26Z","timestamp":1760205086977,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071608715"},{"type":"electronic","value":"9781071608722"}],"license":[{"start":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T00:00:00Z","timestamp":1598054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T00:00:00Z","timestamp":1598054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-0872-2_17","type":"book-chapter","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T17:02:46Z","timestamp":1598029366000},"page":"307-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ethics of DNA Vaccine Transfer for Clinical Research"],"prefix":"10.1007","author":[{"given":"Ana Cristina","family":"Ramalhinho","sequence":"first","affiliation":[]},{"given":"Miguel","family":"Castelo-Branco","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,8,22]]},"reference":[{"key":"17_CR1","volume-title":"DNA vaccines: scientific and ethical barriers to the vaccines of the future","author":"A Zhang","year":"2015","unstructured":"Zhang A (2015) DNA vaccines: scientific and ethical barriers to the vaccines of the future. Harvard College Global Health Review, Cambridge"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21775\/cimb.022.079","volume":"22","author":"AI Myhr","year":"2017","unstructured":"Myhr AI (2017) DNA vaccines: regulatory considerations and safety aspects. Curr Issues Mol Biol 22:79\u201388","journal-title":"Curr Issues Mol Biol"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.vaccine.2004.01.011","volume":"22","author":"RE Spier","year":"2004","unstructured":"Spier RE (2004) Ethical aspects of the methods used to evaluate the safety of vaccines. Vaccine 22:2085\u20132090","journal-title":"Vaccine"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/cid\/cir334","volume":"53","author":"S Plotkin","year":"2011","unstructured":"Plotkin S (2011) Clinical applications of DNA vaccines: current progress. Clin Infect Dis 53:296\u2013302","journal-title":"Clin Infect Dis"},{"key":"17_CR5","unstructured":"Parents Requesting Open Vaccine Education (PROVE) (2000) Conflicts of interest in vaccine policy making. Majority Staff Report, Committee on Government Reform, U.S. House of Representatives"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/medethics-2015-103292","volume":"42","author":"A Doussau","year":"2016","unstructured":"Doussau A, Grady C (2016) Deciphering assumptions about step wedge designs: the case of Ebola vaccine research. J Med Ethics 42:797\u2013804","journal-title":"J Med Ethics"},{"key":"17_CR7","unstructured":"Bhanot N, Mehta K (2012) Wrong at every step: the licensing of HPV vaccines. Mainstream Weekly 32"},{"issue":"2","key":"17_CR8","first-page":"88","volume":"2","author":"V Johari","year":"2017","unstructured":"Johari V (2017) Identifying ethical issues in the development of vaccines and in vaccination. Indian J Med Ethics 2(2):88\u201393","journal-title":"Indian J Med Ethics"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1080\/21645515.2016.1272744","volume":"13","author":"M Molyneux","year":"2017","unstructured":"Molyneux M (2017) New ethical considerations in vaccine trials. Hum Vaccin Immunother 13:2160\u20132163","journal-title":"Hum Vaccin Immunother"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/annonc\/mdf209","volume":"8","author":"HEM van Luijn","year":"2002","unstructured":"van Luijn HEM, Musschenga AW, Keus RB et al (2002) Assessment of the risk\/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members. Ann Oncol 8:1307\u20131313","journal-title":"Ann Oncol"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/jama.283.20.2701","volume":"283","author":"EJ Emanuel","year":"2000","unstructured":"Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical. JAMA 283:2701\u20132711","journal-title":"JAMA"},{"key":"17_CR12","unstructured":"ICH (2015) Integrated addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2)"},{"key":"17_CR13","unstructured":"EMA (2013) Reflection paper on risk-based quality management in clinical trials"},{"key":"17_CR14","volume-title":"Clinical trials: a methodologic perspective","author":"S Piantadosi","year":"2013","unstructured":"Piantadosi S (2013) Clinical trials: a methodologic perspective. John Wiley & Sons, Hoboken, NJ"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4103\/2231-4040.116779","volume":"4","author":"LP Nijhawan","year":"2013","unstructured":"Nijhawan LP, Janodia MD, Muddukrishna BS et al (2013) Informed consent: issues and challenges. J Adv Pharm Technol Res 4:134\u2013140","journal-title":"J Adv Pharm Technol Res"},{"key":"17_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/picr.PICR_147_16","volume":"8","author":"RA Kadam","year":"2017","unstructured":"Kadam RA (2017) Informed consent process: a step further towards making it meaningful! Perspect Clin Res 8:107\u2013112","journal-title":"Perspect Clin Res"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/2229-3485.148794","volume":"6","author":"RB Ghooi","year":"2015","unstructured":"Ghooi RB (2015) Conflict of interest in clinical research. Perspect Clin Res 6:10\u201314","journal-title":"Perspect Clin Res"}],"container-title":["Methods in Molecular Biology","DNA Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0872-2_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T08:57:11Z","timestamp":1723453031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-0872-2_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,22]]},"ISBN":["9781071608715","9781071608722"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0872-2_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2020,8,22]]},"assertion":[{"value":"22 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}